相关实验视频

Updated: May 30, 2025

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

对含有编码抗微生物的遗传序列的工程T7菌体的分析

Tobias Ludwig¹, Daniela Volke¹, Andor Krizsan¹

¹Institute of Bioanalytical Chemistry, Faculty of Chemistry and Mineralogy, Center for Biotechnology and Biomedicine, Leipzig University, Leipzig, Germany.

Frontiers in antibiotics

|January 30, 2025

概括

研究人员设计了菌体以产生抗微生物,提高它们对抗诸如大肠杆菌等多药耐药细菌的能力. 这种新的菌体治疗方法对抗耐药细菌菌株有希望.

科学领域:

微生物学微生物学
生物技术是生物技术.
抗微生物耐药性抗微生物耐药性

背景情况:

多种和泛耐药细菌的兴起需要新的治疗策略.
菌体治疗为传统抗生素提供了一个有希望的替代方案.
之前的研究表明,转基因T7菌产生抗菌素 (AMP).

研究的目的:

为了优化T7细菌菌体内apidaecin衍生物的表达.
增强基于菌体的抗微生物策略对抗耐药性大肠杆菌的疗效.
调查结合菌体与AMP的协同效应.

主要方法:

用OmpA分泌信号对T7菌体进行基因改造,以表达阿皮代辛衍生物 (Api805).
用单个和双个副本构建菌体的 *OmpA*-Api805插入.
工程菌体来表达来自cathelicidin相关AMP (CRAMP) 和melittin的DNA序列.
评估工程菌体对抗菌体耐药性大肠杆菌的抗菌活性.

主要成果:

具有两份OmpA-Api805插入物的T7菌体显示出改善了对菌体抗性大肠杆菌的抑制.
OmpA分泌信号可以防止对宿主细胞的有害影响.
结合使用T7菌体与CRAMP和梅利丁增强了细菌溶解,并防止了耐药性的发展.
工程T7Select-(M) CRAMP和T7Select-(M) 梅利丁菌体部分抑制了耐性大肠杆菌在溶解后的生长.

结论:

基因工程培养的表达抗微生物的菌体代表了对抗耐药细菌的可行策略.
优化的表达和分泌提高了菌体的疗效.
将细菌治疗与抗微生物结合起来,可以克服细菌耐药机制.
这种方法有可能开发用于细菌感染的新疗法.

关键词:

一个叫做CRAMP的.这是一种OmpA信号.抗微生物 (AMP) 是一种抗微生物.这种药物有助于治疗疹.细菌菌体是一种细菌体.梅利蒂尼尼 (Melittin) 是一个小岛屿.菌体工程是什么菌体工程协同效应是一种协同效应.

更多相关视频

Quantitative PCR of T7 Bacteriophage from Biopanning

Quantitative PCR of T7 Bacteriophage from Biopanning

Published on: September 27, 2018

Understanding the Impact of Temperate Bacteriophages on Their Lysogens Through Transcriptomics

Understanding the Impact of Temperate Bacteriophages on Their Lysogens Through Transcriptomics

Published on: January 5, 2024

相关概念视频

Lytic Cycle of Bacteriophages

Lytic Cycle of Bacteriophages

Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...

CRISPR and crRNAs

CRISPR and crRNAs

Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...

Antibiotic Selection

Antibiotic Selection

Antimicrobial Proteins

Antimicrobial Proteins

Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...